Catalyst Wire Dossier Catalyst Wire Dossier

Edaravone Dexborneol Concentrated Solution for Injection

edaravone dexborneol · Simcere Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Edaravone Dexborneol Concentrated Solution for Injection, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of Different Doses of Edaravone Dexborneol Concentrated Solution for Injection Combined With Conventional Medical Therapy in the Treatment of Patients With Cerebral Hemorrhage [Phase 2]

See pricing